Patients still on OST 2018/12/31 (n = 181) | Hospital-based unit (n = 89) | Downtown unit n = 92 | |||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | End of study | p valued | Baseline | End of study | p valued | Baseline | End of study | p valued | |
Sex (M/F) | 173/8 | - | - | 86/3 | - | - | 87/5 | - | |
Age (Years, mean (SD)) | 45.5 (9.7) | - | - | 44.6 (9.5) | - | - | 46.4 (9.8) | - | - |
Treatmenta (buprenorphine/methadone/suboxone) | - | 142/35/4 | - | 70/17/2 | - | - | 72/18/2 | - | |
anti-HCVb ( ±) | 103/76 | 103/77 | n.s | 50/37 | 50/38 | n.s | 53/39 | 53/39 | n.s |
HCV RNA/Ag ( ±) | 67/36 | 46/58 | 0.003 | 31/19 | 18/32 | 0.009 | 36/17 | 28/26 | n.s |
Patients attending Clinic of Infectious Diseasesc (yes/no) | 35/32 | 31/15 | n.s | 21/10 | 12/6 | n.s | 14/22 | 19/9 | 0.009 |
Time to last HCV-test, years (median, IQR) | 1.2 (0.3–4.0) | 1.3 (0.6–1.8) | 0.002 | 5.0 (1.0–5.0) | 1.3 (0.3–1.7) | < 0.0001 | 0.6 (0.3–1.7) | 1.3 (0.7–1.8) | n.s |